How The Brains of ‘Super Agers’ Stay Young

Human brain with flower colors (Shutterstock) 
Human brain with flower colors (Shutterstock) 
TT

How The Brains of ‘Super Agers’ Stay Young

Human brain with flower colors (Shutterstock) 
Human brain with flower colors (Shutterstock) 

The secret of how “super agers” have the mental agility of people decades younger has been discovered, according to The Telegraph.

Scientists have found that some elderly people are able to regenerate brain cells twice as quickly as healthy adults of the same age.

It has only recently been shown that people continue creating brain cells throughout their life, with researchers previously believing that humans were born with all the brain cells they will ever have.

The new research suggests that some people age without any signs of cognitive decline because their bodies are much better at renewing brain cells – a process known as neurogenesis – which protects them from diseases such as Alzheimer’s.

“Super agers had twice the neurogenesis of the other healthy older adults,” said Professor Orly Lazarov, of the University of Illinois at Chicago (UIC).

“Something in their brains enables them to maintain a superior memory. I believe hippocampal neurogenesis is the secret ingredient, and the data support that,” she said.

Lazarov added that, “This is a big step forward in understanding how the human brain processes cognition, forms memories and ages.”

A super ager is someone aged 80 or older who exhibits cognitive function that is comparable to an average person who is middle-aged.

To find out why their brains were still so nimble, scientists looked at donated brain samples from five groups: healthy young adults; healthy older adults; older adults with exceptional memory – or super agers; individuals with mild or early dementia; and those diagnosed with Alzheimer’s disease.

Researchers searched for three stages of developing brain cells; neuroblasts – the most primitive cells; adolescent stem cells on their way to neuronhood; and immature neurons, which are just shy of becoming functional.

They found that brains of older adults with super healthy cognition grow more new neurons than those of their peers, while those diagnosed with Alzheimer’s disease generated almost no new neurons.

Scientists hope that if they can find out what is driving the extra brain-cell development, they can create drugs or lifestyle interventions to boost healthy ageing and prevent diseases such as Alzheimer’s.

For example, previous research has shown that exercise produces a protein called cathepsin B which travels to the brain and triggers neuron growth.

“What’s exciting for the public is that this study shows the ageing brain is not fixed or doomed to decline,” said Ahmed Disouky, the first author of the study from UIC.

“Understanding how some people naturally maintain neurogenesis opens the door to strategies that could help more adults preserve memory and cognitive health as they age,” he said.



India Moves Closer to Dengue Vaccine as Final Trials Underway

Patients suffering from dengue fever receive medical treatment at Civil Hospital in Karachi, Pakistan, 05 November 2025. EPA/SHAHZAIB AKBER
Patients suffering from dengue fever receive medical treatment at Civil Hospital in Karachi, Pakistan, 05 November 2025. EPA/SHAHZAIB AKBER
TT

India Moves Closer to Dengue Vaccine as Final Trials Underway

Patients suffering from dengue fever receive medical treatment at Civil Hospital in Karachi, Pakistan, 05 November 2025. EPA/SHAHZAIB AKBER
Patients suffering from dengue fever receive medical treatment at Civil Hospital in Karachi, Pakistan, 05 November 2025. EPA/SHAHZAIB AKBER

As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots against the deadly mosquito-borne disease.

Dengue, which causes severe flu-like symptoms and debilitating body aches, has exploded globally, fueled by rising temperatures and densely populated cities.

The World Health Organization (WHO) says that almost half the world's population is now at risk, with 100-400 million infections every year. India alone has recorded over one million cases and at least 1,500 deaths since 2021.

Hoping to stem the global epidemic, Panacea Biotec has begun final Phase III trials of its vaccine, DengiAll, which has been pursuing for nearly 15 years.

More than 10,000 volunteers across the country are enrolled in the study, overseen by the Indian Council of Medical Research, with the vaccine on track for rollout as early as next year if the trial results are favorable.

"We will try to get this vaccine out there as soon as possible," Syed Khalid Ali, chief scientific officer of Panacea, told AFP in New Delhi.

Doctor Ekta Gupta, professor of clinical virology at the Institute of Liver and Biliary Sciences in New Delhi, said dengue was now considered hyperendemic in India, with all four virus serotypes circulating simultaneously.

"This vaccine is very much needed right now to control the occurrence of these cases, or at least prevent the severity."

- Climate change -

Monsoon outbreaks regularly push Indian hospitals to their limits, crowding urban wards and leaving rural regions grappling with late diagnoses and poor access to care.

Higher temperatures and changing rainfall patterns create ideal conditions for Aedes mosquitoes -- the vectors of dengue -- to reproduce and spread the virus.

Children are particularly vulnerable to the more severe form, called dengue hemorrhagic fever, as they are more likely to suffer low platelet counts and shock.

Participants in Phase III trials, which started in 2024, were randomly assigned to receive either the vaccine or a placebo, with the results expected later this year.

Vaccines against all four dengue serotypes have long posed a scientific challenge. Immunity to one strain does not protect against others, and secondary infections can be more severe.

Most existing candidates require multiple doses.

If approved, DengiAll would become one of the world's first single-dose dengue vaccines, following Brazil's approval of a similar shot last year.

It would also be the first such vaccine available in India, where no dengue shot is currently licensed for public use.

"We will be the second (single-dose) vaccine to come out... But in India and several lower-middle-income countries, we will be the first ones to roll out the dengue vaccine," Ali said.

The candidate is based on a tetravalent strain originally developed by the US National Institutes of Health.

- 'Hope for future' -

Panacea is the most advanced of three Indian firms licensed to use the strain, having developed its own formulation and secured a process patent.

Inside the company's research labs, doctor Priyanka Priyadarsiny, head of biological R&D, said vaccine development involves several steps, from proof-of-concept studies to regulatory checks.

"We are extremely cautious about purity, safety and adverse effects," she said. "Only after meeting regulatory specifications can a product be considered safe for public use."

At present, the WHO recommends only one dengue vaccine, Qdenga, produced by Japan's Takeda for children aged six to 16 in high-transmission settings.

Qdenga, which requires two doses administered three months apart, is not currently available in India.

Ali said DengiAll could be given to people aged one to 60 and is expected to offer long-term protection.

In India, final approval would come from the Drug Controller General of India, while WHO prequalification would be required for large-scale international use.

Experts say a successful Indian-made vaccine could be key to affordability and mass rollout in lower-income countries.

Virologist and Oxford University fellow Shahid Jameel -- who is not connected with the trial -- warned dengue incidence could rise by 50-75 percent by 2050 under current climate change trends.

Still, he cautioned that only Phase III results would determine whether a candidate meets the criteria for a safe and effective dengue vaccine.

"Phase III testing and follow-up are needed to show if the above conditions are met," he told AFP.

"Only then can we have a useful dengue vaccine. It is still early days, but there is hope for the future."


Oil Spill from Cargo Ship Washes up on Thai Tourist Islands 

People walk along Patong Beach in Phuket, Thailand, June 29, 2021. (AFP)
People walk along Patong Beach in Phuket, Thailand, June 29, 2021. (AFP)
TT

Oil Spill from Cargo Ship Washes up on Thai Tourist Islands 

People walk along Patong Beach in Phuket, Thailand, June 29, 2021. (AFP)
People walk along Patong Beach in Phuket, Thailand, June 29, 2021. (AFP)

An oil spill from a capsized cargo ship in the Indian Ocean is washing ashore on the pristine beaches of Thailand's most famous resort island, a lawmaker told AFP Friday.

The Panama-flagged Sealloyd Arc sank off Phuket on February 7 while sailing for Chattogram in Bangladesh, Thai authorities said, spilling around 1,700 liters of oil.

The coagulated residue has begun washing up on the island's Ya Nui Beach, as well as a smattering of smaller islands in Phuket province, local lawmaker Chalermpong Saengdee told AFP.

The oil has tainted Koh Hey's Banana Beach -- a popular destination for island-hopping tourists seeking turquoise clear waters -- and is expected to keep spreading, he said.

"It's very worrying because the incident happened two weeks ago, but the situation is not improving and it poses a threat to marine life and coastal reefs," he said.

"We are also concerned it could affect Thailand's tourism and economy."

The ship lies at a depth of about 60 meters (197 feet), making it difficult for divers to contain the leak, Chalermpong said.

Footage on public broadcaster Thai PBS showed locals combing beaches with rakes and buckets to collect globs of the oil.

While the Thai Navy has been using dispersants to treat the spillage, Chalermpong has called for government funding to salvage the wreck.

Thailand suffered 130 oil spills affecting more than 23 provinces between 2017 and 2021, according to the Department of Marine and Coastal Resources.

Environmental organizations warn oil spills cause severe and long-lasting damage to ecosystems -- coating wildlife, contaminating food sources and releasing toxic chemicals.


Poland Reportedly Plans Social Media Ban for Children Under 15

FILE PHOTO: Instagram, TikTok, Snapchat, Kick, YouTube, Facebook, Twitch, Reddit, Threads and X applications are displayed on a mobile phone, in this picture illustration taken on December 9, 2025. REUTERS/Hollie Adams/Illustration/File Photo
FILE PHOTO: Instagram, TikTok, Snapchat, Kick, YouTube, Facebook, Twitch, Reddit, Threads and X applications are displayed on a mobile phone, in this picture illustration taken on December 9, 2025. REUTERS/Hollie Adams/Illustration/File Photo
TT

Poland Reportedly Plans Social Media Ban for Children Under 15

FILE PHOTO: Instagram, TikTok, Snapchat, Kick, YouTube, Facebook, Twitch, Reddit, Threads and X applications are displayed on a mobile phone, in this picture illustration taken on December 9, 2025. REUTERS/Hollie Adams/Illustration/File Photo
FILE PHOTO: Instagram, TikTok, Snapchat, Kick, YouTube, Facebook, Twitch, Reddit, Threads and X applications are displayed on a mobile phone, in this picture illustration taken on December 9, 2025. REUTERS/Hollie Adams/Illustration/File Photo

Poland plans ‌to introduce new legislation to ban social media for children under 15 years of age and will hold platforms responsible for age verification, Education Minister Barbara Nowacka told Bloomberg News in an interview published on Friday.

The ruling Civic Coalition will present the draft ‌outline on Friday, ‌with fines planned for ‌platforms ⁠that remain accessible to ⁠younger users, Nowacka said, adding that the law could take effect by early 2027.

"We see the mental health of children and young people, we see ⁠a decline in their intellectual ‌competence," said ‌Nowacka adding that the size of penalties ‌that companies would have ‌to pay is still under discussion.

Several European governments including Denmark, Greece, France, Spain and Britain have explored similar restrictions amid ‌claims that social-media services are harmful or addictive for minors.

The ⁠British ⁠government said in January it was considering restrictions to protect children online, after Australia implemented similar laws in December.

The initiative could put Warsaw at odds with US tech firms such as Meta and Elon Musk's X, some of which have pushed back against restrictions following Australia's ban last year.